"Limit of Detection" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Concentration or quantity that is derived from the smallest measure that can be detected with reasonable certainty for a given analytical procedure.
Descriptor ID |
D057230
|
MeSH Number(s) |
E05.318.740.872.374 N05.715.360.750.725.500 N06.850.520.830.872.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Limit of Detection".
Below are MeSH descriptors whose meaning is more specific than "Limit of Detection".
This graph shows the total number of publications written about "Limit of Detection" by people in this website by year, and whether "Limit of Detection" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2012 | 0 | 1 | 1 |
2013 | 0 | 2 | 2 |
2014 | 0 | 3 | 3 |
2015 | 0 | 2 | 2 |
2016 | 0 | 1 | 1 |
2017 | 0 | 2 | 2 |
2018 | 0 | 1 | 1 |
2019 | 0 | 3 | 3 |
2021 | 0 | 2 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Limit of Detection" by people in Profiles.
-
Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection. Cell Rep Med. 2021 04 20; 2(4):100228.
-
Blood metabolomics in infants enrolled in a dose escalation pilot trial of budesonide in surfactant. Pediatr Res. 2021 10; 90(4):784-794.
-
Clinical Validation and Implementation of a Measurable Residual Disease Assay for NPM1 in Acute Myeloid Leukemia by Error-Corrected Next-Generation Sequencing. Mol Diagn Ther. 2019 12; 23(6):791-802.
-
A biomimetic fluorescent nanosensor based on imprinted polymers modified with carbon dots for sensitive detection of alpha-fetoprotein in clinical samples. Analyst. 2019 Nov 04; 144(22):6760-6772.
-
Ultra-sensitive digital quantification of proteins and mRNA in single cells. Nat Commun. 2019 08 07; 10(1):3544.
-
A Liquid-Chromatography High-Resolution Mass Spectrometry Method for Non-FDA Approved Benzodiazepines. J Anal Toxicol. 2019 May 01; 43(4):316-320.
-
Analytical validation of soluble fms-like tyrosine and placental growth factor assays on B·R·A·H·M·S KRYPTOR Compact Plus automated immunoassay platform. Pregnancy Hypertens. 2018 Jan; 11:66-70.
-
Comparative studies on the multi-component pharmacokinetics of Aristolochiae Fructus and honey-fried Aristolochiae Fructus extracts after oral administration in rats. BMC Complement Altern Med. 2017 Feb 10; 17(1):107.
-
Sensitive simultaneous quantitation of testosterone and estradiol in serum by LC-MS/MS without derivatization and comparison with the CDC HoSt program. J Chromatogr B Analyt Technol Biomed Life Sci. 2017 Mar 24; 1048:70-76.
-
Clinical Validation of a Next-Generation Sequencing Genomic Oncology Panel via Cross-Platform Benchmarking against Established Amplicon Sequencing Assays. J Mol Diagn. 2017 01; 19(1):43-56.